neostigmine has been researched along with Cardiometabolic Syndrome in 1 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Out of 83 patients with prostate cancer, 42 (51%) had Gleason score 6 (12 (28." | 1.37 | Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy. ( Cantiani, A; Carluccini, A; De Nunzio, C; Freedland, SJ; Miano, R; Trucchi, A; Tubaro, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Nunzio, C | 1 |
| Freedland, SJ | 1 |
| Miano, R | 1 |
| Trucchi, A | 1 |
| Cantiani, A | 1 |
| Carluccini, A | 1 |
| Tubaro, A | 1 |
1 other study available for neostigmine and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Metabolic syndrome is associated with high grade Gleason score when prostate cancer is diagnosed on biopsy.
Topics: Aged; Aged, 80 and over; Biopsy; Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol, HDL; D | 2011 |